The Medical News

1. Skin conductance measurements reveal link between insomnia and disrupted fear regulation

   A new computational model using skin conductance measurements to estimate stress-related emotional arousal found a significant difference in learned fear and safety responses over time between adults with and without insomnia.

2. Human accountability remains essential as healthcare adopts AI

   With artificial intelligence making deep inroads into healthcare, two top doctors are urging physicians to embrace the technology but to remember that only humans can serve the best interest of individual patients.

3. Recurrent brain tumors undergo unique genetic changes after treatment

   When patients are diagnosed with certain brain tumors, one of the biggest unanswered questions is what happens when the cancer returns.

4. Experimental gene therapy offers non-surgical option for hydrocephalus

   Researchers at the University of Cincinnati College of Medicine have published the first proof-of-concept study showing the potential of an experimental gene therapy for hydrocephalus.

5. WEHI study reveals a new immune pathway for fighting small cell lung cancer

   Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

6. New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

   A group of scientists led by Joseph Brown, assistant professor at the Leslie Dan Faculty of Pharmacy, has received $2.3 million USD in funding to develop a database and AI training model to identify peptides with therapeutic potential.

7. Aged aircraft exhaust poses a rising threat to human health

   Fine particulate matter consists of tiny particles with diameters in the nanometer range. They are produced, for example, by fuel combustion, remain suspended in the air and can penetrate deep into the respiratory tract.

8. Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus

   The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate of 48 percent.